[Munich, 22 August 2025] – The global syndromic multiplex diagnostics market is projected to grow from USD 4.78 billion in 2024 to USD 9.65 billion by 2031, according to Clearview Market Insights (CVMI). Growth is fueled by rising demand for rapid, accurate detection of co-infections and resistance genes in both high-throughput laboratories and point-of-care settings.
Syndromic...
A major challenge in the in vitro diagnostics market is navigating complex regulatory requirements. Diagnostic products must meet stringent standards for safety, quality, and efficacy before approval. These processes often vary across countries, creating additional difficulties for global companies. Lengthy approval timelines can delay market entry, limiting revenue potential. Smaller...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek